SOUTH Tipperary is to benefit from a much needed jobs boost, following the announcement on Monday that medical technology giant Boston Scientific is to invest over E26m in an R&D plant at its Clonmel facility. The news comes in the wake of dreadful economic news for the County, which now has an umemployment rate of about 14%. Just recently, Johnson and Johnson announced the closure of its Cashel plant resulting in over 200 job losses.
Boston Scientific’s investment will enable it to significantly expand its research and design, and technical capabilities related to the design of the company’s next-generation “cardiac rhythm management devices” manufactured at the Clonmel facility. These devices allow physicians to maintain a patient’s heart rate at a steady beat, treating a range of cardiac diseases.
The investment is supported by the Government through IDA Ireland. Deputy Tom Hayes said he was delighted that Boston Scientific had chosen Clonmel. “I am delighted to confirm news of this investment, following talks with the Minister for Enterprise, Jobs and Innovation Richard Bruton. The investment is a huge boost to Clonmel, and clearly demonstrates the company’s commitment to remaining in the region for the long term.
“This injection of capital will enable Boston Scientific to significantly expand its R&D and technical capabilities related to the design of the company’s next generation cardiac rhythm management devices manufactured at the Tipperary facility.
“Boston Scientific is a major player in the medical devices industry and as a result makes a significant contribution to the Irish economy every year. The Government and the IDA have worked closely with the company to secure this investment.
“The company has been operating here since 1994 and is one of the country’s largest employers. Announcements like that made this week indicate the firm’s desire to remain in Ireland into the future. It also serves as a testament to the strength and talent of the workforce in Clonmel.
“As stated by Minister Bruton, if we want to create jobs and growth we must relentlessly promote an innovation agenda. High value investments by leading multinationals like Boston Scientific not only create employment, but also provide a positive spin off benefit for the wider economy.
“This announcement is fantastic news for the county. It will only encourage both myself and the Minister to work even harder to continue to bring as much investment and job creation to South Tipperary as possible over the coming few years,” added Deputy Hayes.
Minister Bruton said: “This investment is great news for Clonmel, and we must seize this opportunity to ensure that investments like this can be replicated across the country to create jobs and get the economy growing again.”
Brad Sorenson, Vice President of Operations for Boston Scientific, said: “This local funding will benefit our Cardiology, Rhythm and Vascular Group by enhancing our ability to provide R&D, design and manufacturing support for our leading medical device technologies. I am confident that, with the talent and expertise of our Clonmel staff, we can continue to successfully commercialize new life-saving innovations for our customers and their patients worldwide.”
“Boston Scientific is a major player in the medical technologies sector in Ireland and makes a substantial contribution to our economy each year,” added Barry O’Leary, CEO of IDA Ireland. “This R&D investment in Clonmel perfectly demonstrates the transformation agenda set out in IDA’s strategy Horizon 2020. IDA worked closely with the Company to secure this R&D investment and we look forward to helping to facilitate its future development plans.”
Boston Scientific established operations in Ireland in 1994 and is one of the country’s largest employers, with campuses in Clonmel, Galway and Cork.